Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
CVS Health's (NYSE: CVS) latest results affirm several points: their sales and adjusted profits remain stable, and they are adjusting their forecasts upward. Nonetheless, the quality of their profits and elevated debt still render the stock a “cheap but risky” option, rather than a definitive bargain.
CVS wants investors to know it sees bigger profits ahead, and has new AI plans.
| Health Care Providers & Services Industry | Healthcare Sector | J. David Joyner CEBS CEO | XMUN Exchange | US1266501006 ISIN |
| US Country | 219,000 Employees | 23 Oct 2025 Last Dividend | 7 Jun 2005 Last Split | 17 Dec 1984 IPO Date |
CVS Health Corporation is a leading provider of health solutions in the United States, with a comprehensive portfolio that spans across Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness sectors. As an integral part of the healthcare ecosystem, CVS Health offers a broad range of products and services designed to meet the needs of various stakeholders, including employers, individuals, health plans, and governmental entities. Initially named CVS Caremark Corporation, the company underwent a rebranding to CVS Health Corporation in September 2014, emphasizing its broadened focus on health and wellness. Founded in 1996 and headquartered in Woonsocket, Rhode Island, CVS Health has grown into a cornerstone of the American healthcare industry, continually evolving to address the complex challenges of modern healthcare.
CVS Health Corporation offers a diversified array of healthcare products and services, categorized into three main segments: